Is flecainide dangerous in long QT-3 patients?

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 1, 2009, Pages 143-145

  Beinart, Roy ^b   Michailidis, Athanasios ^b   Gurevitz, Osnat T ^b   Glikson, Michael ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Defibrillation ICD; Long QT

Indexed keywords

BISOPROLOL; FLECAINIDE;

ADULT; ANAMNESIS; ARTICLE; BRUGADA SYNDROME; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAM; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; LONG QT 3 SYNDROME; LONG QT SYNDROME; PHENOTYPE; QT INTERVAL; SINUS RHYTHM; SYNCOPE;

ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HUMANS; LONG QT SYNDROME; SYNCOPE; YOUNG ADULT;

EID: 58149204436     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02190.x     Document Type: Article

References (7)

1. Benhorin J, Taub R, Goldmit M, Kerem B, Kass RS, Windman I, Medina A. Effects of flecainide in patients with new SCN5A mutation: Mutation-specific therapy for long QT syndrome? Circulation 2000 101 : 1698 1706.
2. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, et al. Proposed diagnostic criteria for the Brugada syndrome: Consensus report. Circulation 2002 106 : 2514 2519.
3. Shimizu W. Acquired Forms of Brugada Syndrome. In : Antzelevitch C (ed. The Brugada Syndrome: From Bench to Bedside, Chapter 14, Oxford, UK, Blackwell Futura, 2004, pp. 166 177.
4. Baroudi G, Pouliot V, Denjoy I, Guicheney P, Shrier A, Chahine M. Novel mechanism for Brugada syndrome: Defective surface localization of an SCN5A mutant (R1432G). Circ Res 2001 88 : E78 E83.
5. Abriel H, Cabo C, Wehrens XH, Rivolta I, Motoike HK, Memmi M, Napolitano C, et al. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na channel. Circ Res 2001 88 : 740 745.
6. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000 101 : 510 515.
7. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E. The elusive link between LQT3 and Brugada syndrome: The role of flecainide challenge. Circulation 2000 102 : 945 947.